VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Clinically suspected scrub typhus: defined as      │ Clinically suspected scrub typhus: defined as      │     100 │
│ acute undifferentiated fever with no clear focus   │ acute undifferentiated fever with no clear focus   │         │
│ of infection and negative malaria blood smear      │ of infection and negative malaria blood smear      │         │
│ and/or negative malaria RDT. Patients may have     │ and/or negative malaria RDT. Patients may have     │         │
│ one, none, or a combination of other clinical      │ one, none, or a combination of other clinical      │         │
│ findings such as eschar, rash, lymphadenopathy,    │ findings such as eschar, rash, lymphadenopathy,    │         │
│ headache, myalgia, cough, nausea and abdominal     │ headache, myalgia, cough, nausea and abdominal     │         │
│ discomfort                                         │ discomfort                                         │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ A positive scrub typhus RDT (Scrub Typhus IgM RDT, │ A positive scrub typhus RDT (Scrub Typhus IgM RDT, │     100 │
│ InBios International, Seattle, WA, USA) and/or     │ InBios International, Seattle, WA, USA) and/or     │         │
│ positive PCR-based detection of O. tsutsugamushi   │ positive PCR-based detection of O. tsutsugamushi   │         │
│ DNA from the admission blood sample                │ DNA from the admission blood sample                │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Written informed consent and/or, written informed  │ Written informed consent and/or, written informed  │     100 │
│ assent as required                                 │ assent as required                                 │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Able to take oral medication                       │ Able to take oral medication                       │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Known hypersensitivity to tetracycline,            │ Known hypersensitivity to tetracycline,            │     100 │
│ doxycycline or azithromycin                        │ doxycycline or azithromycin                        │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Administration of doxycycline, azithromycin,       │ Administration of doxycycline, azithromycin,       │     100 │
│ chloramphenicol, rifampicin, or tetracycline       │ chloramphenicol, rifampicin, or tetracycline       │         │
│ during the preceding 7 days                        │ during the preceding 7 days                        │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Pregnancy or breast-feeding                        │ Pregnancy or breast-feeding                        │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patients with myasthenia gravis or systemic lupus  │ Patients with myasthenia gravis or systemic lupus  │     100 │
│ erythematosus                                      │ erythematosus                                      │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patients with an established infection (diagnostic │ Patients with an established infection (diagnostic │     100 │
│ test required) e.g. acute malaria, dengue,         │ test required) e.g. acute malaria, dengue,         │         │
│ leptospirosis, typhoid, Japanese encephalitis etc  │ leptospirosis, typhoid, Japanese encephalitis etc  │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Current HAART use for HIV, long term use of        │ Current HAART use for HIV, long term use of        │     100 │
│ immunosuppressants (e.g. steroids, chemotherapy,   │ immunosuppressants (e.g. steroids, chemotherapy,   │         │
│ TNF-inhibitors and related agents)                 │ TNF-inhibitors and related agents)                 │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patients with severe disease whom the clinical     │ Patients with severe disease whom the clinical     │     100 │
│ team feel their condition necessitates the need    │ team feel their condition necessitates the need    │         │
│ for additional scrub typhus treatment beyond the   │ for additional scrub typhus treatment beyond the   │         │
│ allocated antibiotic treatment assigned at         │ allocated antibiotic treatment assigned at         │         │
│ randomization (e.g. IV chloramphenicol and/or      │ randomization (e.g. IV chloramphenicol and/or      │         │
│ PO/NG rifampicin)                                  │ PO/NG rifampicin)                                  │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Age ≥ 15 years old                                 │ Age = 15 years old                                 │      94 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Hospitalization with acute undifferentiated fever  │ Hospitalization with acute undifferentiated fever  │      98 │
│ (temperature \> 37.5°C, tympanic) ≤14 days or      │ (temperature > 37.5 C, tympanic) =14 days or       │         │
│ patients admitted to hospital with a history of    │ patients admitted to hospital with a history of    │         │
│ fever ≤ 14 days who subsequently develop fever     │ fever = 14 days who subsequently develop fever     │         │
│ within 24 hours of admission                       │ within 24 hours of admission                       │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Current TB or TB treatment in ≤ 6 months (contain  │ Current TB or TB treatment in = 6 months (contain  │      99 │
│ active antibiotics against Orientia spp.)          │ active antibiotics against Orientia spp.)          │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════╤════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria      │   Score │
╞═══════════════════════════════════╪════════════════════╪═════════╡
│ Must have minimum age of 15 Years │ Age = 15 years old │      43 │
╘═══════════════════════════════════╧════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 99
Average Levenshtein Ratio of individual lines: 95.6
OverAll Ratio: 97.3
